TECHNOLOGY SUMMARY

Photodynamic therapy (PDT) and photobiomodulation therapy (PBMT) have been demonstrated as minimally invasive or noninvasive strategies to treat cancers and infections, stimulate wound repair, reduce pain, promote hair growth, etc. Widespread clinical adoption has been hindered by current equipment based on lasers or light emitting diode (LED) arrays which are expensive, heavy, and rigid; in addition, expensive in-office visits are usually required for treatments. QLEDCures’ patent-pending technology is based on record breaking ultrabright quantum dot light emitting diodes (QLEDs) that can work as thin, light weight and large area wearable light emitting bandage-type products for use in PDT or PBMT, such that patients can receive treatment while doing daily tasks with minimal interruption. In addition, the inherent tunability of the quantum dots means our QLEDs can be customized for specific medical conditions. The technology has been proven effective in preliminary in-vitro PBMT and PDT studies carried out by leading photomedicine experts and holds promise to enable widespread clinical adoption of PDT and PBMT to transform healthcare industry in managing cancer, acute and chronic wounds, inflammation, combat antibiotic-resistant bacteria, aesthetic medicine, etc. The total addressable market is on the order of tens of billions of dollars.

AREA/MATURITY/AWARDS

Primary Application Area: Medical Devices

Technology Development Status: Prototype

Technology Readiness Level: TRL 3

Vetted Programs/Awards: 2017 A. Ward Ford Award from American Society for Laser Medicine and Surgery (ASLMS)
Finalist in the Merck 2017 Displaying Future Competition
Journal of the Society for Information Display (JSID)'s Outstanding Student Paper Award of 2017
NSF I-corps site program at University of Central Florida, 2018

SHOWCASE SUMMARY

Organization Type: Early-stage Startup (Seed)

Showcase Booth #: 14M

Website: https://qledcures.com/

GOVT/EXTERNAL FUNDING SOURCES